<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Consilium Medicum</journal-id><journal-title-group><journal-title xml:lang="en">Consilium Medicum</journal-title><trans-title-group xml:lang="ru"><trans-title>Consilium Medicum</trans-title></trans-title-group><trans-title-group xml:lang="zh"><trans-title>Consilium Medicum</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2075-1753</issn><issn publication-format="electronic">2542-2170</issn><publisher><publisher-name xml:lang="en">Consilium Medicum</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">680799</article-id><article-id pub-id-type="doi">10.26442/20751753.2025.4.203317</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Modern possibilities of the diagnosing of primary hyperparathyroidism</article-title><trans-title-group xml:lang="ru"><trans-title>Современные возможности диагностики первичного гиперпаратиреоза</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0037-6222</contrib-id><name-alternatives><name xml:lang="en"><surname>Boriskova</surname><given-names>Marina E.</given-names></name><name xml:lang="ru"><surname>Борискова</surname><given-names>Марина Евгеньевна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>
</p><p>
</p><p>
</p><p>D. Sci. (Med.), Prof., Head of Department</p>


</bio><bio xml:lang="ru"><p>д-р мед. наук, проф. каф. общей хирургии с клиникой, проф. каф. онкологии фак-та последипломного образования, рук. отд-ния хирургической эндокринологии и пластической хирургии</p></bio><email>boriskovam@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6909-1858</contrib-id><name-alternatives><name xml:lang="en"><surname>Pankova</surname><given-names>Polina A.</given-names></name><name xml:lang="ru"><surname>Панкова</surname><given-names>Полина Александровна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>
</p><p>
</p><p>
</p><p>Cand. Sci. (Med.), Assist.</p>


</bio><bio xml:lang="ru"><p>канд. мед. наук, ассистент каф. общей хирургии с клиникой</p></bio><email>boriskovam@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0004-7557-1809</contrib-id><name-alternatives><name xml:lang="en"><surname>Khamid</surname><given-names>Lina A.</given-names></name><name xml:lang="ru"><surname>Хамид</surname><given-names>Лина Абдовна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Student</p></bio><bio xml:lang="ru"><p>студентка лечебного фак-та</p></bio><email>boriskovam@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6806-1414</contrib-id><name-alternatives><name xml:lang="en"><surname>Bykov</surname><given-names>Mikhail A.</given-names></name><name xml:lang="ru"><surname>Быков</surname><given-names>Михаил Андрианович</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Cand. Sci. (Med.), Surgeon</p></bio><bio xml:lang="ru"><p>канд. мед. наук, врач-хирург отд-ния хирургической эндокринологии и пластической хирургии</p></bio><email>boriskovam@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7951-7402</contrib-id><name-alternatives><name xml:lang="en"><surname>Zuykevich</surname><given-names>Daria V.</given-names></name><name xml:lang="ru"><surname>Зуйкевич</surname><given-names>Дарья Владимировна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Lab. Assist.</p></bio><bio xml:lang="ru"><p>ст. лаборант каф. общей хирургии с клиникой</p></bio><email>boriskovam@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5120-1142</contrib-id><name-alternatives><name xml:lang="en"><surname>Valiakhmedova</surname><given-names>Kristina V.</given-names></name><name xml:lang="ru"><surname>Валиахмедова</surname><given-names>Кристина Валерьевна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Surgeon</p></bio><bio xml:lang="ru"><p>врач-хирург</p></bio><email>boriskovam@gmail.com</email><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2097-2881</contrib-id><name-alternatives><name xml:lang="en"><surname>Ulimbasheva</surname><given-names>Zalina M.</given-names></name><name xml:lang="ru"><surname>Улимбашева</surname><given-names>Залина Муазиновна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Cand. Sci. (Med.), Surgeon</p></bio><bio xml:lang="ru"><p>канд. мед. наук, врач-хирург отд-ния хирургической эндокринологии и пластической хирургии </p></bio><email>boriskovam@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0628-0085</contrib-id><name-alternatives><name xml:lang="en"><surname>Pogosy0an</surname><given-names>Karina A.</given-names></name><name xml:lang="ru"><surname>Погосян</surname><given-names>Карина Александровна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Jun. Res.</p></bio><bio xml:lang="ru"><p>мл. науч. сотр. научно-исследовательской лаб. нейроэндокринных опухолей Научного исследовательского центра персонализированной онкологии</p></bio><email>boriskovam@gmail.com</email><xref ref-type="aff" rid="aff3"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1547-0123</contrib-id><name-alternatives><name xml:lang="en"><surname>Karonova</surname><given-names>Tatiana L.</given-names></name><name xml:lang="ru"><surname>Каронова</surname><given-names>Татьяна Леонидовна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>D. Sci. (Med.), Head of Laboratory, Chief Res.</p></bio><bio xml:lang="ru"><p>д-р мед. наук, зав. научно-исследовательской лаб. новой коронавирусной инфекции и постковидного синдрома Научного центра мирового уровня «Центр персонализированной медицины», гл. науч. сотр. научно-исследовательской лаб. клинической эндокринологии Института эндокринологии</p></bio><email>boriskovam@gmail.com</email><xref ref-type="aff" rid="aff3"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7086-9153</contrib-id><name-alternatives><name xml:lang="en"><surname>Ryzhkova</surname><given-names>Daria V.</given-names></name><name xml:lang="ru"><surname>Рыжкова</surname><given-names>Дарья Викторовна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>D. Sci. (Med.), Prof., Head of Department</p></bio><bio xml:lang="ru"><p>д-р мед. наук, проф. РАН, зав. каф. ядерной медицины и радиационных технологий с клиникой Института медицинского образования</p></bio><email>boriskovam@gmail.com</email><xref ref-type="aff" rid="aff3"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Pavlov First Saint Petersburg State Medical University</institution></aff><aff><institution xml:lang="ru">Первый Санкт-Петербургский государственный медицинский университет им. акад. И.П. Павлова</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">My Medical Center Group</institution></aff><aff><institution xml:lang="ru">Группа компаний «Мой медицинский центр»</institution></aff></aff-alternatives><aff-alternatives id="aff3"><aff><institution xml:lang="en">Almazov National Medical Research Centre</institution></aff><aff><institution xml:lang="ru">Национальный медицинский исследовательский центр им. В.А. Алмазова</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2025-04-25" publication-format="electronic"><day>25</day><month>04</month><year>2025</year></pub-date><volume>27</volume><issue>4</issue><issue-title xml:lang="en">Endocrinology</issue-title><issue-title xml:lang="ru">Эндокринология</issue-title><fpage>223</fpage><lpage>228</lpage><history><date date-type="received" iso-8601-date="2025-05-29"><day>29</day><month>05</month><year>2025</year></date><date date-type="accepted" iso-8601-date="2025-06-16"><day>16</day><month>06</month><year>2025</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2025, Consilium Medicum</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2025, ООО "Консилиум Медикум"</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="en">Consilium Medicum</copyright-holder><copyright-holder xml:lang="ru">ООО "Консилиум Медикум"</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by-nc-sa/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://consilium.orscience.ru/2075-1753/article/view/680799">https://consilium.orscience.ru/2075-1753/article/view/680799</self-uri><abstract xml:lang="en"><p><bold>Background.</bold> Currently, the most common method of preoperative imaging of affected parathyroid glands (PTG) is a combination of scintigraphy with technetium [99mTc] sestamibi and neck ultrasound (with a sensitivity of 81–95%). In some cases, such as multiple PTG lesions, their ectopic location, multiple nodular thyroid lesions, and their hyperfunction or inflammation, standard imaging methods may show negative or contradictory results, which requires the use of 2nd-line diagnostic studies. One is positron emission tomography combined with computed tomography (PET/CT) with 11C-choline.</p> <p><bold>Aim. </bold>To determine the role of PET/CT with 11C-choline in the topical diagnosis of primary hyperparathyroidism.</p> <p><bold>Materials and methods.</bold> Retrospective analysis of data from 33 patients with primary hyperparathyroidism who underwent parathyroidectomy at the Department of Surgical Endocrinology of Pavlov First Saint Petersburg State Medical University from 2022 to 2024. Due to the ineffectiveness of standard imaging and/or the persistence of primary hyperparathyroidism after the first surgery, all patients included in the study underwent PET/CT with 11C-choline (Almazov National Medical Research Centre). The accuracy, sensitivity, specificity, and positive and negative predictive values were calculated considering the pathological postoperative verification of adenoma/hyperplasia and/or achievement of the reference range of parathyroid hormone and calcium plasma levels.</p> <p><bold>Results.</bold> A total of 41 masses were removed in 33 patients (8 patients had 2 masses removed each). Thirty-seven areas were positive according to PET/CT with 11C-choline. Its diagnostic accuracy was 95.5%, sensitivity 90.2%, specificity 97.8%, positive predictive value 94.9%, and negative predictive value 95.7%.</p> <p><bold>Conclusion.</bold> PET/CT with 11C-choline demonstrated high efficacy in preoperative localization assessment of PTG adenomas, even in cases where the results of first-line imaging methods were ambiguous. We use this method in complex cases, although it can be considered an alternative to first-line imaging. This question remains open and requires further studies comparing economic feasibility.</p></abstract><trans-abstract xml:lang="ru"><p><bold>Обоснование.</bold> В настоящее время наиболее распространенный метод предоперационной визуализации пораженных паращитовидных желез (ПЩЖ) – сочетание сцинтиграфии с Технеция [99mTс] сестамиби и ультразвукового исследования шеи (чувствительность – 81–95%). В ряде случаев, таких как множественное поражение ПЩЖ, их эктопическое расположение, множественные узловые поражения щитовидной железы, ее гиперфункция или воспаление, стандартные методы визуализации могут показывать отрицательные или противоречивые результаты, что требует обращения к диагностирующим исследованиям 2-й линии. Одно из них – позитронно-эмиссионная томография, совмещенная с компьютерной томографией (ПЭТ/КТ) с 11С-холином.</p> <p><bold>Цель.</bold> Определить место ПЭТ/КТ с 11С-холином в топической диагностике первичного гиперпаратиреоза.</p> <p><bold>Материалы и методы.</bold> Приведен ретроспективный анализ данных 33 пациентов с первичным гиперпаратиреозом, которым с 2022 по 2024 г. в отделении хирургической эндокринологии ФГБОУ ВО «Первый СПб ГМУ им. акад. И.П. Павлова» проведена паратиреоидэктомия. Всем включенным в исследование пациентам в связи с неэффективностью стандартной визуализации и/или персистенцией первичного гиперпаратиреоза после 1-й операции выполнена ПЭТ/КТ с 11С-холином (ФГБУ «НМИЦ им. В.А. Алмазова»). Точность, чувствительность, специфичность, прогностическая ценность положительного и отрицательного результатов оценивались с учетом патоморфологической послеоперационной верификации аденомы/гиперплазии и/или достижения референсного диапазона концентрации паратиреоидного гормона и кальция в плазме крови.</p> <p><bold>Результаты.</bold> У 33 пациентов удалено в общей сложности 41 образование (у 8 человек – по 2 образования). Положительными по ПЭТ/КТ с 11С-холином были 37 зон. Ее диагностическая точность составила 95,5%, чувствительность – 90,2%, специфичность – 97,8%, положительная прогностическая ценность – 94,9%, отрицательная прогностическая ценность – 95,7%.</p> <p><bold>Заключение.</bold> ПЭТ/КТ с 11С-холином продемонстрировала высокую эффективность в предоперационной оценке локализации аденом ПЩЖ, даже в тех случаях, когда результаты визуализации методов 1-й линии оказались неоднозначными. Мы используем метод в сложных случаях, хотя потенциально он может рассматриваться как альтернатива методам 1-й линии. Этот вопрос остается открытым и требует накопления достаточного количества исследований, сравнивающих экономическую целесообразность.</p></trans-abstract><kwd-group xml:lang="en"><kwd>primary hyperparathyroidism</kwd><kwd>PET/CT</kwd><kwd>11C-choline</kwd><kwd>scintigraphy</kwd><kwd>ultrasound</kwd><kwd>selective parathyroidectomy</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>первичный гиперпаратиреоз</kwd><kwd>ПЭТ/КТ</kwd><kwd>11С-холин</kwd><kwd>сцинтиграфия</kwd><kwd>ультразвуковое исследование</kwd><kwd>селективная паратиреоидэктомия</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Bilezikian JP, Brandi ML, Eastell R, et al. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop. J Clin Endocrinol Metab. 2014;99(10):3561-9. DOI:10.1210/jc.2014-1413</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Felger EA, Kandil E. Primary hyperparathyroidism. Otolaryngol Clin North Am. 2010;43(2):417-32. DOI:10.1016/j.otc.2010.01.009</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Insogna KL. Primary Hyperparathyroidism. N Engl J Med. 2018;379(11):1050-9. DOI:10.1056/NEJMcp1714213</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>DeLellis RA, Mazzaglia P, Mangray S. Primary hyperparathyroidism: a current perspective. Arch Pathol Lab Med. 2008;132(8):1251-62. DOI:10.5858/2008-132-1251-PHACP</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Lloyd RV, Osamura RY, Klöppel G, Rosai J. WHO Classification of Tumours of Endocrine Organs. Lyon, France: International Agency for Research on Cancer, 2017.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Morris MA, Saboury B, Ahlman M, et al. Parathyroid Imaging: Past, Present, and Future. Front Endocrinol (Lausanne). 2022;25;12:760419. DOI:10.3389/fendo.2021.760419</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Sukan A, Reyhan M, Aydin M, et al. Preoperative evaluation of hyperparathyroidism: the role of dual-phase parathyroid scintigraphy and ultrasound imaging. Ann Nucl Med. 2008;22(2):123-31. DOI:10.1007/s12149-007-0086-z</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Patel CN, Salahudeen HM, Lansdown M, Scarsbrook AF. Clinical utility of ultrasound and 99mTc sestamibi SPECT/CT for preoperative localization of parathyroid adenoma in patients with primary hyperparathyroidism. Clin Radiol. 2010;65(4):278-87. DOI:10.1016/j.crad.2009.12.005</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Hodolic M, Huchet V, Balogova S, et al. Incidental uptake of (18)F-fluorocholine (FCH) in the head or in the neck of patients with prostate cancer. Radiol Oncol. 2014;48(3):228-34. DOI:10.2478/raon-2013-0075</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Khokar AM, Kuchta KM, Moo-Young TA, et al. Increasing trend of bilateral neck exploration in primary hyperparathyroidism. Am J Surg. 2020;219(3):466-70. DOI:10.1016/j.amjsurg.2019.09.039</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Chakrabarty N, Mahajan A, Basu S, D'Cruz AK. Imaging Recommendations for Diagnosis and Management of Primary Parathyroid Pathologies: A Comprehensive Review. Cancers (Basel). 2024;16(14):2593. DOI:10.3390/cancers16142593</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Gough I (2006) Reoperative parathyroid surgery: the importance of ectopic location and multigland disease. ANZ J Surg. 76:1048-50. DOI:10.1111/j.1445-2197.2006.03931.x</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Jaskowiak N, Norton JA, Alexander HR, et al. A prospective trial evaluating a standard approach to reoperation for missed parathyroid adenoma. Ann Surg. 1996;224:308-20. DOI:10.1097/00000658-199609000-00007</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Bergenfelz AO, Wallin G, Jansson S, et al. Results of surgery for sporadic primary hyperparathyroidism in patients with preoperatively negative sestamibi scintigraphy and ultrasound. Langenbeck’s Arch Surg. 2011;396:83-90. DOI:10.1007/s00423-010-0724-0</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Parikh PP, Farra JC, Allan BJ, et al. Long-term effectiveness of localization studies and intraoperative parathormone monitoring in patients undergoing reoperative parathyroidectomy for persistent or recurrent hyperparathyroidism. Am J Surg. 2015;210:117-22 DOI: 10.1016/j.amjsurg.2014.09.039</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Karakas E, Muller HH, Schlosshauer T, et al. Reoperations for primary hyperparathyroidism –improvement of outcome over two decades. Langenbeck’s Arch Surg. 2013;398:99-106. DOI: 10.1007/s00423-012-1004-y</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Мокрышева Н.Г., Еремкина А.К., Мирная С.С., и др. Клинические рекомендации по первичному гиперпаратиреозу, краткая версия. Проблемы эндокринологии. 2021;4. Режим доступа: https://cyberleninka.ru/article/n/klinicheskie-rekomendatsii-po-pervichnomu-giperparatireozu-kratkaya-versiya. Ссылка активна на 12.02.2025 [Mokrysheva NG, Eremkina AK, Mirnaia SS, et al. Klinicheskie rekomendatsii po pervichnomu giperparatireozu, kratkaia versiia. Problemy endokrinologii. 2021;4. Available at: https://cyberleninka.ru/article/n/klinicheskie-rekomendatsii-po-pervichnomu-giperparatireozu-kratkaya-versiya. Accessed: 12.02.2025 (in Russian)]. DOI:10.14341/probl12801</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Животов В.А., Дрожжин А.Ю., Ветшев П.С. Топическая диагностика поражений околощитовидных желез. Вестник Национального медико-хирургического центра им. Н.И. Пирогова. 2017;4-2. Режим доступа: https://cyberleninka.ru/article/n/topicheskaya-diagnostika-porazheniy-okoloschitovidnyh-zhelez. Ссылка активна на 12.02.2025 [Zhivotov VA, Drozhzhin AIu, Vetshev PS. Topicheskaia diagnostika porazhenii okoloshchitovidnykh zhelez. Vestnik Natsionalnogo mediko-khirurgicheskogo tsentra im. N.I. Pirogova. 2017;4-2. Available at: https://cyberleninka.ru/article/n/topicheskaya-diagnostika-porazheniy-okoloschitovidnyh-zhelez Accessed: 12.02.2025 (in Russian)].</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Zafereo M, Yu J, Angelos P, Brumund K, et al. American Head and Neck Society Endocrine Surgery Section update on parathyroid imaging for surgical candidates with primary hyperparathyroidism. Head Neck. 2019;41(7):2398-409. DOI:10.1002/hed.25781</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Petranović Ovčariček P, Giovanella L, Carrió Gasset I, et al. The EANM practice guidelines for parathyroid imaging. Eur J Nucl Med Mol Imaging. 2021;48(9):2801-22. DOI:10.1007/s00259-021-05334-y</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Udelsman R. Six hundred fifty-six consecutive explorations for primary hyperparathyroidism. Ann Surg. 2002;235(5):665-70. DOI:10.1097/00000658-200205000-00008</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Harari A, Mitmaker E, Grogan RH, et al. Primary hyperparathyroidism patients with positive preoperative sestamibi scan and negative ultrasound are more likely to have posteriorly located upper gland adenomas (PLUGs). Ann Surg Oncol. 2011;18(6):1717-22. DOI:10.1245/s10434-010-1493-2</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Zhang Z, Zhao M, Chen B, et al. Comparative Analysis of Diagnostic Efficacy in Primary Hyperparathyroidism: A Comparison Analysis of 11C-Choline PET/CT, Neck Ultrasonography, 99mTc-MIBI Dual-Phase Planar Scintigraphy, and 99mTc-MIBI SPECT/CT Imaging. J Cancer. 2024;15(7):1863-9. DOI:10.7150/jca.91483</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Orevi M, Freedman N, Mishani E, et al. Localization of parathyroid adenoma by ¹¹C-choline PET/CT: preliminary results. Clin Nucl Med. 2014;39(12):1033-8. DOI:10.1097/RLU.0000000000000607</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Ismail A, Christensen JW, Krakauer M, et al. 11C-Choline PET/CT vs. 99mTc-MIBI/123Iodide Subtraction SPECT/CT for Preoperative Detection of Abnormal Parathyroid Glands in Primary Hyperparathyroidism: A Prospective, Single-Centre Clinical Trial in 60 Patients. Diagnostics (Basel). 2020;10(11):975. DOI:10.3390/diagnostics10110975</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Liu Y, Dang Y, Huo L, et al. Preoperative Localization of Adenomas in Primary Hyperparathyroidism: The Value of 11C-Choline PET/CT in Patients with Negative or Discordant Findings on Ultrasonography and 99mTc-Sestamibi SPECT/CT. J Nucl Med. 2020;61(4):584-9. DOI:10.2967/jnumed.119.233213</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Погосян К.А., Каронова Т.Л., Рыжкова Д.В., и др. Сравнение ПЭТ/КТ С 11С-метионином и 11С-холином при визуализации аденом околощитовидных желез: проспективное исследование. Лучевая диагностика и терапия. 2024;15(2):45-52 [Pogosian KА, Karonova TL, Ryzhkova DV, et al. Comparision of 11C-methionine and 11C-choline pet/ct for parathyroid visualization: a prospective study. Diagnostic radiology and radiotherapy. 2024;15(2):45-52 (in Russian)]. DOI:10.22328/2079-5343-2024-15-2-45-52</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>Parvinian A, Martin-Macintosh EL, Goenka AH, et al. 11C-Choline PET/CT for Detection and Localization of Parathyroid Adenomas. AJR Am J Roentgenol. 2018;210(2):418-22. DOI:10.2214/AJR.17.18312</mixed-citation></ref></ref-list></back></article>
